AvalehtLCTX • NYSEAMERICAN
add
Lineage Cell Therapeutics Inc
0,42 $
Pärast sulgemist:(6,19%)+0,026
0,44 $
Suletud: 16. apr, 19:59:54 GMT −4 · USD · NYSEAMERICAN · Välistus
Viimane sulgemishind
0,43 $
Tänane vahemik
0,42 $ - 0,45 $
Aasta vahemik
0,37 $ - 1,40 $
Turuväärtus
94,94 mln USD
Keskmine maht
1,69 mln
P/E suhe
-
Dividendimäär
-
Börsiuudised
Teave
Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. With this platform Lineage develops and manufactures specialized, terminally differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed to either replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer. Wikipedia
Asutatud
1990
Veebisait
Töötajate arv
74